(hypoxia / HIF-1α / LXRα / gastric cancer / prognosis)
R. Guo, B. Yang
Department of General Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, China
Pages: 91 - 101 (PDF)
Corresponding author: Bin Yang, Department of General Surgery, Shanxi Cancer Hospital, No.3, Zhigongxincun, Xinghualing District, Taiyuan City, Shanxi, 030013, China. Phone: (+0086) 180 035 165 10; e-mail: yangbin81@tom.com
J. XIE1, Y. SUN1, Q. XU2
1Department of Gastroenterology, The First Affiliated Hospital of Yangtez University, the First People’s Hospital of Jingzhou, Jingzhou City, Hubei Province, China
2Department of Medical Oncology, Minhang District Oncology Hospital, Shanghai City, 200240, China
Pages: 102 - 107 (PDF)
Corresponding author: Qiaoling Xu, Department of Medical Oncology, Minhang District Oncology Hospital, No.106 Ruili Road, Minhang District, Shanghai City, China. Phone: (+86) 021-6462 9290; e-mail: xuqiaoling0203@163.com
B. F. YAN1,2,†, X. Chen3,†, J. Liu1, S. J. Liu2, J. Z. Zhang1, Q. Q. Zeng1, J. A. Duan2
1Jiangsu Health Vocational College; Nanjing, China
2Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, and Key Laboratory of Chinese Medicinal Resources Recycling Utilization, State Administration of Traditional Chinese Medicine, Nanjing University of Chinese Medicine; Nanjing, China
3Jiangsu College of Nursing; Huaian, China
Pages: 108 - 117 (PDF)
Corresponding author: Qingqi Zeng, Jiangsu Health Vocational College, Nanjing 210023, Jiangsu Province, China. Phone / Fax: +86 25 6817 2750; e-mail: zengqq111@126.com.
Z. M. ZHANG1#, L. MIN2#, D. L. JIANG3, Z. Y HAN3, L. H. WANG3
1Department of Critical Care Medicine, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Department of Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
3Department of Clinical laboratory, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China
Pages: 118 - 125 (PDF)
Corresponding author: Lihua Wang, Department of Clinical laboratory, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan City, Hubei, 442008, PR China. Phone: (+086) 0719 8210666; e-mail: lihuawang666@163. com.
(luteoloside / non-alcoholic fatty liver disease / STAT3 / hepatocyte regeneration)
Y. X. ZHU1, L. ZHU1, Y. F. Chen1, J. M. Xu1, Z. L. SHEN1, R. J. Liu1, J. ZOU1, M. Q. YUAN1, F. YE1, Q. Q. Zeng2
1Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan 215300, Jiangshu, China
2Jiangsu Health Vocational College; Nanjing 210023, China
Pages: 126 - 133 (PDF)
Corresponding author: Fan Ye, Mingqing Yuan, Qingqi Zeng, Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, NO. 91, Qianjin West Road, Yushan Town, Kunshan, Jiangshu, China. E-mail: yefan870914@163.com (F. Y.), sanchao2003@126.com (M. Q. Y.), zengqq111@126.com (Q. Q. Z.)